Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals
Sponsor: Million Marker Wellness, Inc.
Summary
The goal of this clinical trial is to learn if a personalized biomonitoring report-back and educational intervention in child-bearing aged men and women can reduce endocrine disrupting chemicals (EDCs) measured in urine, increase participants' understanding of environmental health (environmental health literacy; EHL), increase their readiness and behaviors to reduce exposures, and improve their well-being. The intervention includes EDC testing and exposure report-back, a self-directed online interactive curriculum with access to live coaches, and an online forum. The investigators hypothesize that the intervention will be more effective than EDC testing and report-back alone at reducing EDC exposures (behavior change and metabolite concentrations), as well as increasing EHL, readiness to reduce exposures, and well-being.
Official title: A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals Among a Child-Bearing Age Cohort
Key Details
Gender
All
Age Range
18 Years - 44 Years
Study Type
INTERVENTIONAL
Enrollment
600
Start Date
2024-05-23
Completion Date
2026-08-01
Last Updated
2025-12-08
Healthy Volunteers
Yes
Conditions
Interventions
Urinary EDC metabolite testing
Mail-in urine samples tested for metabolites of bisphenols, phthalates, parabens, and oxybenzone.
Educational curriculum
A self-directed online interactive curriculum of EDC material, with access to live coaches and an online forum.
Locations (1)
Renown Health
Reno, Nevada, United States